Analyst Reco.

17/02 Rothschild & Co Redburn Adjusts Price Target on West Pharmaceutical Services to $312 From $325, Maintains Buy Rating MT
13/02 Stephens Cuts Price Target on West Pharmaceutical Services to $320 From $350, Maintains Overweight Rating MT
13/02 UBS Adjusts West Pharmaceutical Services Price Target to $340 From $355, Maintains Buy Rating MT
13/02 Barclays Adjusts West Pharmaceutical Services PT to $265 From $325, Maintains Equal Weight Rating MT
10/02 Jefferies Adjusts Price Target on West Pharmaceutical Services to $295 From $365, Maintains Buy Rating MT
03/02 Evercore ISI Adjusts Price Target on West Pharmaceutical Services to $320 From $390 MT
19/12 Deutsche Bank Adjusts West Pharmaceutical Services Price Target to $340 From $345, Maintains Buy Rating MT
02/12 Morgan Stanley Initiates West Pharmaceutical Services at Equalweight With $285 Price Target MT
31/25/31 Rothschild & Co Redburn Adjusts Price Target on West Pharmaceutical Services to $325 From $311 MT
29/25/29 TD Cowen Initiates West Pharmaceutical Services at Buy With $350 Price Target MT
27/25/27 Stephens Adjusts Price Target on West Pharmaceutical Services to $350 From $335 MT
27/25/27 Jefferies Adjusts Price Target on West Pharmaceutical Services to $365 From $335, Maintains Buy Rating MT
24/25/24 Barclays Adjusts West Pharmaceutical Services Price Target to $325 From $275 MT
24/25/24 West Pharmaceutical Services Set for Growth After Solid Q3, BofA Securities Says MT
24/25/24 UBS Adjusts Price Target on West Pharmaceutical Services to $355 From $320, Maintains Buy Rating MT
24/25/24 Deutsche Bank Adjusts West Pharmaceutical Services Price Target to $345 From $305, Maintains Buy Rating MT
24/25/24 KeyBanc Adjusts West Pharmaceutical Services Price Target to $350 From $325, Maintains Overweight Rating MT
23/25/23 Citigroup Adjusts Price Target on West Pharmaceutical Services to $375 From $350, Maintains Buy Rating MT
23/25/23 Evercore ISI Adjusts West Pharmaceutical Services PT to $390 From $350, Maintains Outperform Rating MT
23/25/23 West Pharmaceutical beats Q3 net sales estimates; lifts FY revenue, EPS outlook RE
16/25/16 Deutsche Bank Adjusts West Pharmaceutical Services Price Target to $305 From $280, Maintains Buy Rating MT
02/25/02 Barclays Adjusts Price Target on West Pharmaceutical Services to $275 From $260, Maintains Equalweight Rating MT
25/25/25 Analyst recommendations: Boeing, Intel, Qualcomm, Reddit, Snap… Zonebourse
15/25/15 Rothschild & Co Redburn Initiates West Pharmaceutical Services at Buy With $311 Price Target MT
15/25/15 Rothschild & Co Redburn Initiates West Pharmaceutical Services at Buy With $311 Price Target MT
No results for this search
SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW